CDK19 and neoplasm: Thus, after high expression in cases of human PC being reported [49], the cyclin-dependent kinase 19 (CDK19) was identified as a specific and sensitive biomarker for the diagnosis of high-grade PIN, reflecting its involvement in the progression of neoplastic disease, as well as its malignant potential [50].